LUSEFI Trademark

Trademark Overview

On Friday, December 7, 2012, a trademark application was filed for LUSEFI with the United States Patent and Trademark Office. The USPTO has given the LUSEFI trademark a serial number of 79126599. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, February 21, 2020. This trademark is owned by Taisho Pharmaceutical Co., Ltd.. The LUSEFI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for human use, namely, for the treatment of diabetes
lusefi

General Information

Serial Number79126599
Word MarkLUSEFI
Filing DateFriday, December 7, 2012
Status709 - CANCELLED - SECTION 71
Status DateFriday, February 21, 2020
Registration Number4366612
Registration DateTuesday, July 16, 2013
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 30, 2013

Trademark Statements

Goods and ServicesPharmaceutical preparations for human use, namely, for the treatment of diabetes

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, February 21, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameTaisho Pharmaceutical Co., Ltd.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressJP
Party NameTaisho Pharmaceutical Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressJP
Party NameTaisho Pharmaceutical Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressJP

Trademark Events

Event DateEvent Description
Monday, December 5, 2022INTERNATIONAL REGISTRATION RENEWED
Saturday, December 12, 2020TOTAL INVALIDATION PROCESSED BY THE IB
Friday, November 13, 2020TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Thursday, November 12, 2020INVALIDATION PROCESSED
Wednesday, October 21, 2020TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Saturday, October 10, 2020FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, July 17, 2020NOTIFICATION PROCESSED BY IB
Friday, February 21, 2020CANCELLED SECTION 71
Friday, November 8, 2019REFUSAL PROCESSED BY IB
Thursday, May 1, 2014NEW REPRESENTATIVE AT IB RECEIVED
Friday, August 30, 2013NOTIFICATION PROCESSED BY IB
Thursday, August 15, 2013FINAL DISPOSITION NOTICE SENT TO IB
Thursday, August 15, 2013FINAL DISPOSITION PROCESSED
Thursday, August 15, 2013GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Tuesday, July 16, 2013REGISTERED-PRINCIPAL REGISTER
Tuesday, April 30, 2013PUBLISHED FOR OPPOSITION
Wednesday, April 10, 2013NOTICE OF PUBLICATION
Wednesday, March 27, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, March 27, 2013ASSIGNED TO LIE
Tuesday, March 26, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 26, 2013ASSIGNED TO EXAMINER
Saturday, March 23, 2013APPLICATION FILING RECEIPT MAILED
Tuesday, March 19, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, March 18, 2013LIMITATION FROM ORIGINAL APPLICATION ENTERED
Friday, March 15, 2013SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

lusefi treatment diabetes namely human preparations pharmaceutical